Medicare Part D Coverage For Humira Biosimilars Has Inspector General’s Attention

 
• By Cathy Kelly
  
syringes_full_of_dollars
An Important Test Case For The Viability Of Biosimilars • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation